[Contrast-enhanced sonography using Levovist is decisive for staging and therapeutic schedule in hepatocellular carcinoma].
D000368:Aged; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D003911:Dextrans; D005260:Female; D052203:Ferrosoferric Oxide; D006498:Hepatectomy; D006801:Humans; D007501:Iron; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D010087:Oxides; D011134:Polysaccharides; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D011134:Polysaccharides; C059891:SHU 508; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide
Kontrastmittelsonographie der Leber als wegweisende Untersuchung für die Therapieplanung des hepatozellulären Karzinoms.